Luis Carlos Salazar Alvarez
Papers
1
Total Citations
2
H-Index
1
About
Luis Carlos Salazar Alvarez is a pioneering researcher in antimalarial drug discovery, with a specialized focus on *Plasmodium vivax*—the most widespread human malaria parasite. His work centers on developing innovative, target-based screening platforms to identify inhibitors of essential parasite enzymes, particularly deoxyhypusine synthase (DHS), which catalyzes the unique hypusine modification of eukaryotic translation factor 5A (eIF5A)—a modification critical for cell viability. His landmark 2024 study introduced a groundbreaking yeast-based experimental platform for high-throughput screening of *P. vivax* DHS inhibitors, offering a safer, more efficient alternative to traditional parasite culture methods. This work has already garnered 2 citations and represents a significant methodological advance in antimalarial research. By targeting this essential post-translational modification pathway, Salazar Alvarez opens new avenues for developing drugs that disrupt a fundamental process in the parasite’s life cycle. His contributions are particularly timely given the rise of drug-resistant malaria strains, positioning him as a key figure in the next generation of antimalarial therapeutics.
Research Focus
Key Achievements
Top Papers
- 1